High frequency of intestinal T H 17 cells correlates with microbiota alterations and disease activity in multiple sclerosis

Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy

Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,770 · see citing works

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · see citing works

Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria

Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554 · see citing works

The effect of infections on susceptibility to autoimmune and allergic diseases.

Bach, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,714 · see citing works

Microbiota and SCFA in lean and overweight healthy subjects

Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457 · see citing works

Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine

Ivanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770 · see citing works

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · see citing works

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E. E., Garren, H., Langer-Gould, A. M., Strober, S., Cannella, B., Allard, J. D., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,659 · see citing works

The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses

Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De Paepe, M., Brandi, G., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.020 · Cited by 1,452 · see citing works

Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells

Kleinewietfeld, M., Manzel, A., Titze, J., Kvakan, H., Yosef, N., Linker, R. A., Muller, D. N., & Hafler, D. A. (2013) · Nature · doi:10.1038/nature11868 · Cited by 1,394 · see citing works

Generation of pathogenic TH17 cells in the absence of TGF-β signalling

Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388 · see citing works

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323 · see citing works

Alterations of the human gut microbiome in multiple sclerosis

Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307 · see citing works

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination

Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251 · see citing works

Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects

Radilla-Vázquez, R. B., Parra‐Rojas, I., Martínez-Hernández, N. E., Márquez‐Sandoval, F., Illades‐Aguiar, B., & Castro-Alarcón, N. (2016) · Obesity Facts · doi:10.1159/000442479 · Cited by 1,200 · see citing works

Induction and molecular signature of pathogenic TH17 cells

Lee, Y., Awasthi, A., Yosef, N., Quintana, F. J., Xiao, S., Peters, A., Wu, C., Kleinewietfeld, M., Kunder, S., Hafler, D. A., et al. (2012) · Nature Immunology · doi:10.1038/ni.2416 · Cited by 1,174 · see citing works

Th17 cell induction by adhesion of microbes to intestinal epithelial cells

Atarashi, K., Tanoue, T., Ando, M., Kamada, N., Nagano, Y., Narushima, S., Suda, W., Imaoka, A., Setoyama, H., Nagamori, T., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.058 · Cited by 1,071 · see citing works

Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1

Wu, C., Yosef, N., Thalhamer, T., Zhu, C., Xiao, S., Kishi, Y., Regev, A., & Kuchroo, V. K. (2013) · Nature · doi:10.1038/nature11984 · Cited by 1,022 · see citing works

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls

Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Paz Soldan, M. M., Luckey, D. H., Marietta, E. V., Jeraldo, P. R., Chen, X., et al. (2016) · Scientific Reports · doi:10.1038/srep28484 · Cited by 933 · see citing works

Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters

Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137429 · Cited by 809 · see citing works

Using QIIME to Analyze 16S rRNA Gene Sequences from Microbial Communities

Kuczynski, J., Stombaugh, J., Walters, W. A., González, A., Caporaso, J. G., & Knight, R. D. (2011) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1007s36 · Cited by 730 · see citing works

Using QIIME to Analyze 16S rRNA Gene Sequences from Microbial Communities

Kuczynski, J., Stombaugh, J., Walters, W. A., González, A., Caporaso, J. G., & Knight, R. D. (2012) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc01e05s27 · Cited by 661 · see citing works

Control of TH17 cells occurs in the small intestine

Esplugues, E., Huber, S., Gagliani, N., Hauser, A. E., Town, T., Wan, Y. Y., O’Connor, W., Rongvaux, A., van Rooijen, N., Haberman, A. M., et al. (2011) · Nature · doi:10.1038/nature10228 · Cited by 643 · see citing works

Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice

Li, J., Sung, C. Y. J., Lee, N. P. Y., Ni, Y., Pihlajamäki, J., Panagiotou, G., & El-Nezami, H. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518189113 · Cited by 624 · see citing works

Multiple sclerosis

Nylander, A., & Hafler, D. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58649 · Cited by 495 · see citing works

Toll-like receptor 9–induced type I IFN protects mice from experimental colitis

Katakura, K., Lee, J., Rachmilewitz, D., Li, G. C., Eckmann, L., & Raz, E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22996 · Cited by 450 · see citing works

T cells become licensed in the lung to enter the central nervous system

Odoardi, F., Sie, C., Streyl, K., Ulaganathan, V. K., Schläger, C., Lodygin, D., Heckelsmiller, K., Nietfeld, W., Ellwart, J. W., Klinkert, W. E. F., et al. (2012) · Nature · doi:10.1038/nature11337 · Cited by 440 · see citing works

Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice

Tan, T. G., Sefik, E., Geva-Zatorsky, N., Kua, L., Naskar, D., Teng, F., Pasman, L., Ortiz-Lopez, A., Jupp, R., Wu, H.-J. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617460113 · Cited by 427 · see citing works

Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice

Kriegel, M. A., Sefik, E., Hill, J. A., Wu, H.-J. J., Benoist, C. O., & Mathis, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108924108 · Cited by 423 · see citing works

Gut microbiota in multiple sclerosis: possible influence of immunomodulators

Cantarel, B. L., Waubant, E., Chehoud, C., Kuczynski, J., DeSantis, T. Z., Warrington, J., Venkatesan, A., Fraser, C. M., & Mowry, E. M. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000192 · Cited by 409 · see citing works

Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.

Pette, M., Fujita, K., Wilkinson, D., Altmann, D. M., Trowsdale, J., Giegerich, G., Hinkkanen, A., Epplen, J. T., Kappos, L., & Wekerle, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.20.7968 · Cited by 307 · see citing works

Enteric Viruses Ameliorate Gut Inflammation via Toll-like Receptor 3 and Toll-like Receptor 7-Mediated Interferon-β Production

Yang, J., Kim, M., Kim, E., Cheon, J. H., Lee, Y. S., Kim, Y., Lee, S.-H., Seo, S., Shin, S., Choi, S. S., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.009 · Cited by 198 · see citing works

Comparative analysis of the distribution of segmented filamentous bacteria in humans, mice and chickens

Yin, Y., Wang, Y., Zhu, L., Liu, W., Liao, N., Jiang, M., Zhu, B., Yu, H. D., Xiang, C., & Wang, X. (2012) · The ISME Journal · doi:10.1038/ismej.2012.128 · Cited by 155 · see citing works

Freedom from disease activity in multiple sclerosis

Havrdová, E., Galetta, S. L., Stefoski, D., & Comı, G. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dbb51c · Cited by 140 · see citing works

Intestinal, segmented, filamentous bacteria in a wide range of vertebrate species

Klaasen, H. L. B. M., Koopman, J. P., Brink, M. E. V. D., Bakker, M. H., Poelma, F. G. J., & Beynen, A. C. (1993) · Laboratory Animals · doi:10.1258/002367793780810441 · Cited by 139 · see citing works

Intestinal, segmented, filamentous bacteria

Klaasen, H. L. B. M., Koopman, J. P., Poelma, F. G. J., & Beynen, A. C. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb04986.x · Cited by 132 · see citing works

Use of tuf Sequences for Genus-Specific PCR Detection and Phylogenetic Analysis of 28 Streptococcal Species

Picard, F. J., Ke, D., Boudreau, D. K., Boissinot, M., Huletsky, A., Richard, D., Ouellette, M., Roy, P. H., & Bergeron, M. G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3686-3695.2004 · Cited by 123 · see citing works

Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls

Tremlett, H. L., Fadrosh, D. W., Faruqi, A. A., Hart, J., Roalstad, S., Graves, J. S., Spencer, C. M., Lynch, S. V., Zamvil, S. S., & Waubant, E. L. (2016) · BMC Neurology · doi:10.1186/s12883-016-0703-3 · Cited by 114 · see citing works

The Effect of Probiotics and Gut Microbiota on Th17 Cells

Tanabe, S. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.839665 · Cited by 99 · see citing works

Diet and multiple sclerosis

Lauer, K. (1997) · Neurology · doi:10.1212/wnl.49.2_suppl_2.s55 · Cited by 94 · see citing works

The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis

Korn, T., Anderson, A. C., Bettelli, E., & Oukka, M. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.009 · Cited by 85 · see citing works

Effect of Acidic pH on Expression of Surface-Associated Proteins of Streptococcus oralis

Wilkins, J. C., Beighton, D., & Homer, K. A. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.9.5290-5296.2003 · Cited by 82 · see citing works

Metabolic traits of pathogenic streptococci

Willenborg, J., & Goethe, R. (2016) · FEBS Letters · doi:10.1002/1873-3468.12317 · Cited by 80 · see citing works

Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohnʼs Disease

Assa, A., Butcher, J., Li, J. S. Y., Elkadri, A. A., Sherman, P. M., Muise, A. M., Stintzi, A. P., & Mack, D. R. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000776 · Cited by 78 · see citing works

The Oral Commensal Streptococcus mitis Shows a Mixed Memory Th Cell Signature That Is Similar to and Cross-Reactive with Streptococcus pneumoniae

Engen, S. A., Valen, H. R., Becattini, S., Jarrossay, D., Blix, I. J. S., Petersen, F. C., Sallusto, F., & Schenck, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104306 · Cited by 57 · see citing works

Use of tuf as a target for sequence-based identification of Gram-positive cocci of the genus Enterococcus, Streptococcus, coagulase-negative Staphylococcus, and Lactococcus

Li, X., Xing, J., Li, B., Wang, P., & Liu, J. (2012) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-11-31 · Cited by 55 · see citing works

A study of dietary modification: Perceptions and attitudes of patients with multiple sclerosis

Brenton, J. N., & Goldman, M. D. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.04.009 · Cited by 40 · see citing works

Th17 polarization of memory Th cells in early arthritis: the vasoactive intestinal peptide effect

Jimeno, R., Leceta, J., Garin, M. I., Ortiz, A. M., Mellado, M., Rodrı́guez-Frade, J. M., Martínez, C., Pérez‐García, S., Gomariz, R. P., & Juarranz, Y. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0714-327r · Cited by 37 · see citing works

Multiple Sclerosis: Mechanisms and Immunotherapy

Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938 · see citing works

Fecal Microbiota Transplantation in Neurological Disorders

Vendrik, K. E. W., Ooijevaar, R. E., de Jong, P. R. C., Laman, J. D., van Oosten, B. W., van Hilten, J. J., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Contarino, M. F. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00098 · Cited by 413 · see citing works

The impact of the gut microbiome on extra-intestinal autoimmune diseases

Miyauchi, E., Shimokawa, C., Steimle, A., Desai, M. S., & Ohno, H. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00727-y · Cited by 375 · see citing works

Gut Microbiota Regulation of T Cells During Inflammation and Autoimmunity

Brown, E., Kenny, D. J., & Xavier, R. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041841 · Cited by 310 · see citing works

Gut Microbiome in Progressive Multiple Sclerosis

Cox, L. M., Maghzi, A. H., Liu, S., Tankou, S. K., Dhang, F. H., Willocq, V., Song, A., Wasén, C., Tauhid, S., Chu, R., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26084 · Cited by 292 · see citing works

TH17 cell heterogeneity and its role in tissue inflammation

Schnell, A., Littman, D. R., & Kuchroo, V. K. (2023) · Nature Immunology · doi:10.1038/s41590-022-01387-9 · Cited by 286 · see citing works

Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity

Schnell, A., Huang, L., Singer, M., Singaraju, A., Barilla, R. M., Regan, B. M. L., Bollhagen, A., Thakore, P. I., Dionne, D., Delorey, T. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.018 · Cited by 268 · see citing works

Gut microorganisms act together to exacerbate inflammation in spinal cords

Miyauchi, E., Kim, S.-W., Suda, W., Kawasumi, M., Onawa, S., Taguchi-Atarashi, N., Morita, H., Taylor, T. D., Hattori, M., & Ohno, H. (2020) · Nature · doi:10.1038/s41586-020-2634-9 · Cited by 268 · see citing works

A probiotic modulates the microbiome and immunity in multiple sclerosis

Tankou, S. K., Regev, K., Healy, B. C., Tjon, E. C., Laghi, L., Cox, L. M., Kivisäkk, P., Pierre, I. V., Hrishikesh, L., Gandhi, R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25244 · Cited by 263 · see citing works

Impacts of microbiome metabolites on immune regulation and autoimmunity

Haase, S., Haghikia, A., Wilck, N., Müller, D. N., & Linker, R. A. (2018) · Immunology · doi:10.1111/imm.12933 · Cited by 239 · see citing works

Butyrate suppresses demyelination and enhances remyelination

Chen, T., Noto, D., Hoshino, Y., Mizuno, M., & Miyake, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1552-y · Cited by 229 · see citing works

The microbiota-immune axis as a central mediator of gut-brain communication

Fung, T. C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104714 · Cited by 228 · see citing works

Leveraging diet to engineer the gut microbiome

Wolter, M., Grant, E. T., Boudaud, M., Steimle, A., Pereira, G. V., Martens, E. C., & Desai, M. S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00512-7 · Cited by 211 · see citing works

Polyphenols in the treatment of autoimmune diseases

Khan, H. Z., Sureda, A., Belwal, T., Çetinkaya, S., Süntar, I. P., Tejada, S., Devkota, H. P., Ullah, H., & Aschner, M. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.05.001 · Cited by 222 · see citing works

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression

Calcinotto, A., Brevi, A., Chesi, M., Ferrarese, R., Garcia Perez, L., Grioni, M., Kumar, S., Garbitt, V. M., Sharik, M. E., Henderson, K. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07305-8 · Cited by 223 · see citing works

The role of the gut microbiota in multiple sclerosis

Correale, J., Hohlfeld, R., & Baranzini, S. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00697-8 · Cited by 207 · see citing works

Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity

Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Microbiome · doi:10.1186/s40168-022-01408-7 · Cited by 200 · see citing works

The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials

Schepici, G., Silvestro, S., Bramanti, P., & Mazzon, E. (2019) · Cell Transplantation · doi:10.1177/0963689719873890 · Cited by 187 · see citing works

The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics

Camara-Lemarroy, C. R., Metz, L. M., Meddings, J. B., Sharkey, K. A., & Yong, V. W. (2018) · Brain · doi:10.1093/brain/awy131 · Cited by 188 · see citing works

The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis

Freedman, S. N., Shahi, S. K., & Mangalam, A. K. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0588-x · Cited by 168 · see citing works

Critical role of the gut microbiota in immune responses and cancer immunotherapy

Li, Z., Xiong, W., Zhu, L. W., Wang, J., Zeng, Z., Kołat, D., Li, X., Zhou, D., Xu, X., & Zhao, L.-Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01541-w · Cited by 188 · see citing works

Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis

Zeng, Q., Gong, J., Liu, X., Chen, C., Sun, X., Li, H., Zhou, Y., Cui, C., Wang, Y., Yang, Y., et al. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104468 · Cited by 156 · see citing works

Investigation of probiotics in multiple sclerosis

Tankou, S. K., Regev, K., Healy, B. C., Cox, L. M., Tjon, E., Kivisakk, P., Vanande, I. P., Cook, S., Gandhi, R., Glanz, B., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517737390 · Cited by 156 · see citing works

Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis

Riccio, P., & Rossano, R. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0581-4 · Cited by 156 · see citing works

The multiple sclerosis gut microbiota: A systematic review

Mirza, A., Forbes, J. D., Zhu, F., Bernstein, C. N., Domselaar, G. V., Graham, M., Waubant, E. L., & Tremlett, H. L. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101427 · Cited by 152 · see citing works

Implications of Gut Microbiota in Neurodegenerative Diseases

Zhang, H., Chen, Y., Wang, Z., Xie, G., Liu, M., Yuan, B., Chai, H., Wang, W., & Cheng, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.785644 · Cited by 157 · see citing works

Gut microbiota and Hashimoto’s thyroiditis

Virili, C., Fallahi, P., Antonelli, A., Benvenga, S., & Centanni, M. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9467-y · Cited by 157 · see citing works

Alterations of host-gut microbiome interactions in multiple sclerosis

Cantoni, C., Lin, Q., Dorsett, Y., Ghezzi, L., Liu, Z., Pan, Y., Chen, K., Han, Y., Li, Z., Xiao, H., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2021.103798 · Cited by 149 · see citing works

Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target

Liu, R., Du, S., Zhao, L., Jain, S., Sahay, K., Rizvanov, A. A., Lezhnyova, V., Хайбуллин, Т. И., Martynova, E. V., Khaiboullina, S. F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.996469 · Cited by 153 · see citing works

The role of gut microbiota in T cell immunity and immune mediated disorders

Shim, J. A., Ryu, J. H., Jo, Y., & Hong, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79430 · Cited by 134 · see citing works

Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis

Shahi, S. K., Freedman, S. N., Murra, A. C., Zarei, K., Sompallae, R. R., Gibson-Corley, K. N., Karandikar, N. J., Murray, J. A., & Mangalam, A. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00462 · Cited by 125 · see citing works

The Gut-Brain Axis in Inflammatory Bowel Disease—Current and Future Perspectives

Günther, C., Rothhammer, V., Karow, M., Neurath, M., & Winner, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168870 · Cited by 123 · see citing works

Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome

Bicknell, B. T., Liebert, A. D., Borody, T. J., Herkes, G., McLachlan, C. S., & Kiat, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119577 · Cited by 129 · see citing works

Short-chain fatty acids and gut microbiota in multiple sclerosis

Melbye, P., Olsson, A., Hansen, T. H., Søndergaard, H. B., & Oturai, A. B. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.13045 · Cited by 121 · see citing works

Gut microbiome-mediated regulation of neuroinflammation

Bostick, J. W., Schonhoff, A. M., & Mazmanian, S. K. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102177 · Cited by 118 · see citing works

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes

Reynders, T., Devolder, L., Valles‐Colomer, M., Remoortel, A. V., Joossens, M., Keyser, J. D., Nagels, G., D'hooghe, M. B., & Raes, J. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51004 · Cited by 112 · see citing works

Targeting the gut to treat multiple sclerosis

Ghezzi, L., Cantoni, C., Pinget, G. V., Zhou, Y., & Piccio, L. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143774 · Cited by 114 · see citing works

Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair

Kalafatakis, I., & Karagogeos, D. (2021) · Biomolecules · doi:10.3390/biom11071058 · Cited by 111 · see citing works

The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis

Bălașa, R., Bărcuţean, L., Bălașa, A. F., Moțățăianu, A., Roman-Filip, C., & Manu, D. R. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.02.009 · Cited by 111 · see citing works

Gut Microbiota Interaction with the Central Nervous System throughout Life

Ojeda, J., Ávila, A., & Vidal, P. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061299 · Cited by 107 · see citing works

Disrupting Myelin-Specific Th17 Cell Gut Homing Confers Protection in an Adoptive Transfer Experimental Autoimmune Encephalomyelitis

Duc, D., Vigne, S., Bernier‐Latmani, J., Yersin, Y., Ruiz, F., Gaïa, N., Léo, S., Lazarević, V., Schrenzel, J., Petrova, T. V., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.002 · Cited by 103 · see citing works

The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?

Parodi, B., & de Rosbo, N. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718220 · Cited by 105 · see citing works

Microbiota–gut–brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets

Chen, C., Wang, G., Li, D., & Zhang, F. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00307-1 · Cited by 119 · see citing works

Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance

Tiwari, P., Dwivedi, R., Bansal, M., Tripathi, M., & Dada, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041650 · Cited by 106 · see citing works

Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis

Levi, I., Gurevich, M., Perlman, G., Magalashvili, D., Menascu, S., Bar, N., Godneva, A., Zahavi, L., Chermon, D., Kosower, N., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100246 · Cited by 97 · see citing works

Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain

Xu, H., Huang, H., Zhou, Y., Zhao, H., Xu, J., Shou, D., Liu, Y., Zhou, Y., & Nie, Y. (2021) · Gastroenterology Research and Practice · doi:10.1155/2021/6699268 · Cited by 103 · see citing works

Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome

Callejo, M., Mondéjar‐Parreño, G., Barreira, B., Izquierdo-García, J. L., Morales‐Cano, D., Esquivel‐Ruiz, S., Moreno, L., Cogolludo, A. L., Duarte, J., & Pérez‐Vizcaíno, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-27682-w · Cited by 95 · see citing works

The emerging role of the small intestinal microbiota in human health and disease

Ruigrok, R. A. A. A., Weersma, R. K., & Vila, A. V. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2201155 · Cited by 96 · see citing works

How the Interplay Between the Commensal Microbiota, Gut Barrier Integrity, and Mucosal Immunity Regulates Brain Autoimmunity

Cencicchio, M. A., Conte, M. L., Sorini, C., & Falcone, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01937 · Cited by 88 · see citing works

Exploring the microbiota-Alzheimer’s disease linkage using short-term antibiotic treatment followed by fecal microbiota transplantation

Wang, M., Cao, J., Gong, C., Amakye, W. K., Yao, M., & Ren, J. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.06.003 · Cited by 90 · see citing works

Polysaccharides confer benefits in immune regulation and multiple sclerosis by interacting with gut microbiota

Sun, Y., Zhang, Z., Cheng, L., Zhang, X., Liu, Y., Zhang, R., Weng, P., & Wu, Z. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110675 · Cited by 85 · see citing works

The Gut Microbiome as a Regulator of the Neuroimmune Landscape

Yu, L. W., Agirman, G., & Hsiao, E. Y. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-014237 · Cited by 75 · see citing works

Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis

Bianchimano, P., Britton, G. J., Wallach, D. S., Smith, E. M., Cox, L. M., Liu, S., Iwanowski, K., Weiner, H. L., Faith, J. J., Clemente, J. C., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01364-2 · Cited by 81 · see citing works

Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease

Lopez, J. A., Denkova, M., Ramanathan, S., Dale, R. C., & Brilot, F. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1316 · Cited by 79 · see citing works

Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice

Lin, X., Liu, Y., Ma, L., Ma, X., Shen, L., Ma, X., Chen, Z., Chen, H., Li, D., Su, Z., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02995-z · Cited by 83 · see citing works

Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Buscarinu, M. C., Romano, S., Mechelli, R., Umeton, R. P., Ferraldeschi, M., Fornasiero, A., Reniè, R., Cerasoli, B., Morena, E., Romano, C., et al. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0582-3 · Cited by 76 · see citing works

Commensal Bacteria-Specific CD4+ T Cell Responses in Health and Disease

Sorini, C., Cardoso, R. F., Gagliani, N., & Villablanca, E. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02667 · Cited by 76 · see citing works

Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls

Hertzberg, V., Singh, H., Fournier, C. N., Moustafa, A., Polak, M. A., Kuelbs, C., Torralba, M., Tansey, M. G., Nelson, K. E., & Glass, J. D. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1904994 · Cited by 76 · see citing works

Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome

Camara-Lemarroy, C. R., Metz, L. M., & Yong, V. W. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i37.4217 · Cited by 75 · see citing works

Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells

Anderson, R., Theron, A. J., & Rapoport, B. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02254 · Cited by 72 · see citing works

Th17 cell pathogenicity in autoimmune disease

Park, E., & Ciofani, M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01535-9 · Cited by 75 · see citing works

Gut Microbial Antigenic Mimicry in Autoimmunity

Garabatos, N., & Santamaría, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.873607 · Cited by 74 · see citing works

A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice

Cao, S., Budina, E., Raczy, M. M., Solanki, A., Nguyen, M., Beckman, T. N., Reda, J. W., Hultgren, K., Ang, P. S., Slezak, A. J., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01190-x · Cited by 71 · see citing works

Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness

Yadav, M., Ali, S., Shrode, R. L., Shahi, S. K., Jensen, S. N., Hoang, J., Cassidy, S., Olalde, H. M., Guseva, N. V., Paullus, M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264556 · Cited by 64 · see citing works

Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells

Ohara, D., Takeuchi, Y., & Hirota, K. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01218-x · Cited by 63 · see citing works

Gut dysbiosis and multiple sclerosis

Noto, D., & Miyake, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108380 · Cited by 65 · see citing works

The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology

Buscarinu, M. C., Fornasiero, A., Romano, S., Ferraldeschi, M., Mechelli, R., Reniè, R., Morena, E., Romano, C., Pellicciari, G., Landi, A. C., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01916 · Cited by 62 · see citing works

Identification of a Shared Microbiomic and Metabolomic Profile in Systemic Autoimmune Diseases

Bellocchi, C., Fernández‐Ochoa, Á., Montanelli, G., Vigone, B., Santaniello, A., Quirantes‐Piné, R., Borrás‐Linares, I., Gerosa, M., Artusi, C., Gualtierotti, R., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091291 · Cited by 60 · see citing works

Microbiota-immune interactions: from gut to brain

Salvo‐Romero, E., Stokes, P., & Gareau, M. G. (2020) · LymphoSign Journal · doi:10.14785/lymphosign-2019-0018 · Cited by 61 · see citing works

Beyond Metabolism: The Complex Interplay Between Dietary Phytoestrogens, Gut Bacteria, and Cells of Nervous and Immune Systems

Cady, N. M., Peterson, S. R., Freedman, S. N., & Mangalam, A. K. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00150 · Cited by 60 · see citing works

Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma

Rodríguez-García, A., Arroyo, A., García-Vicente, R., Morales, M. L., Gómez-Gordo, R., Justo, P., Cuéllar, C., Sánchez‐Pina, J. M., López‐Muñoz, N., Alonso, R., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0195 · Cited by 60 · see citing works

Lack of short-chain fatty acids and overgrowth of opportunistic pathogens define dysbiosis of neuromyelitis optica spectrum disorders: A Chinese pilot study

Gong, J., Qiu, W., Zeng, Q., Liu, X., Sun, X., Li, H., Yang, Y., Wu, A., Bao, J., Wang, Y., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518790396 · Cited by 60 · see citing works

Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review

Zhou, H., Zhao, X. Y., Sun, L., Liu, Y., Lv, Y., Gang, X., & Wang, G. (2020) · Disease Markers · doi:10.1155/2020/3936247 · Cited by 59 · see citing works

Western lifestyle and immunopathology of multiple sclerosis

Matveeva, O., Bogie, J. F. J., Hendriks, J. J. A., Linker, R. A., Haghikia, A., & Kleinewietfeld, M. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13583 · Cited by 61 · see citing works

Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer

Bellone, M., Brevi, A., & Huber, S. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-19 · Cited by 59 · see citing works

Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?

Bellucci, G., Rinaldi, V., Buscarinu, M. C., Reniè, R., Bigi, R., Pellicciari, G., Morena, E., Romano, C., Marrone, A., Mechelli, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.755333 · Cited by 59 · see citing works

Gut Microbiota and Autoimmune Diseases: Mechanisms, Treatment, Challenges, and Future Recommendations

Heravi, F. S. (2024) · Current Clinical Microbiology Reports · doi:10.1007/s40588-023-00213-6 · Cited by 65 · see citing works

Gut microbiota and probiotics: Novel immune system modulators in myasthenia gravis?

Rinaldi, E., Consonni, A., Guidesi, E., Elli, M., Mantegazza, R., & Baggi, F. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13567 · Cited by 57 · see citing works

Gut Microbial Dysbiosis and Plasma Metabolic Profile in Individuals With Vitiligo

Ni, Q., Ye, Z., Wang, Y., Chen, J., Zhang, W., Ma, C., Li, K., Liu, Y., Liu, L., Han, Z., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.592248 · Cited by 56 · see citing works

T helper 17 (Th17) cell responses to the gut microbiota in human diseases

Sun, C., Yang, N. Y., Zheng, Z., Liu, D., & Xu, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114483 · Cited by 59 · see citing works

Alcohol shifts gut microbial networks and ameliorates a murine model of neuroinflammation in a sex-specific pattern

Caslin, B., Maguire, C. P., Karmakar, A., Mohler, K., Wylie, D., & Melamed, E. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912359116 · Cited by 54 · see citing works

Dietary Polyphenols, Microbiome, and Multiple Sclerosis: From Molecular Anti-Inflammatory and Neuroprotective Mechanisms to Clinical Evidence

Rosa, G. L., Lonardo, M. S., Cacciapuoti, N., Muscariello, E., Guida, B., Faraonio, R., Santillo, M., & Damiano, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087247 · Cited by 54 · see citing works

Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege

Ma, Y., Sannino, D. R., Linden, J. R., Haigh, S. V., Zhao, B., Grigg, J. B., Zumbo, P., Dündar, F., Butler, D., Profaci, C. P., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163239 · Cited by 51 · see citing works

A diet-dependent host metabolite shapes the gut microbiota to protect from autoimmunity

Alexander, M., Upadhyay, V., Rock, R., Ramirez, L., Trepka, K. R., Puchalska, P., Orellana, D. A., Ang, Q. Y., Whitty, C., Turnbaugh, J. A., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114891 · Cited by 48 · see citing works

Bacteria–Host Interactions in Multiple Sclerosis

Cossu, D., Yokoyama, K., & Hattori, N. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02966 · Cited by 51 · see citing works

Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification

Huang, M., Ji, Q., Huang, H., Wang, X., & Wang, L. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2486519 · Cited by 53 · see citing works

An introduction of the role of probiotics in human infections and autoimmune diseases

Sales‐Campos, H., Soares, S. D. C., & Oliveira, C. J. F. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1621261 · Cited by 50 · see citing works

Social-Stress-Responsive Microbiota Induces Stimulation of Self-Reactive Effector T Helper Cells

Werbner, M., Barsheshet, Y., Werbner, N., Zigdon, M., Averbuch, I., Oren, Z., Brant, B., Elliott, E., Gelberg, S., Titelbaum, M., et al. (2019) · mSystems · doi:10.1128/msystems.00292-18 · Cited by 49 · see citing works

Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications

Wang, X., Liang, Z., Wang, S., Ma, D., Zhu, M., & Feng, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210629145351 · Cited by 48 · see citing works

Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing–Remitting Multiple Sclerosis

Pellizoni, F. P., Leite, A. Z., Rodrigues, N. D. C., Ubaiz, M. J., Gonzaga, M. I., Takaoka, N. N. C., Mariano, V. S., Omori, W. P., Pinheiro, D. G., Matheucci, E., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094621 · Cited by 48 · see citing works

Impact of Microbiome–Brain Communication on Neuroinflammation and Neurodegeneration

Stolzer, I., Scherer, E., Süß, P., Rothhammer, V., Winner, B., Neurath, M. F., & Günther, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914925 · Cited by 47 · see citing works

Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis

Montgomery, T. L., Wang, Q., Mirza, A., Dwyer, D., Wu, Q., Dowling, C. A., Martens, J. W. S., Yang, J., Krementsov, D. N., & Mao‐Draayer, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-64369-x · Cited by 48 · see citing works

Myalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities

Morris, G., Puri, B. K., Walker, A. J., Maes, M. H. J., Carvalho, A. F., Walder, K. R., Mazza, C., & Berk, M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104450 · Cited by 47 · see citing works

Human Commensal Prevotella histicola Ameliorates Disease as Effectively as Interferon-Beta in the Experimental Autoimmune Encephalomyelitis

Shahi, S. K., Jensen, S. N., Murra, A. C., Tang, N., Guo, H., Gibson-Corley, K. N., Zhang, J., Karandikar, N. J., Murray, J. A., & Mangalam, A. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.578648 · Cited by 46 · see citing works

Comparison of the Intestinal Microbiome of Italian Patients with Multiple Sclerosis and Their Household Relatives

Galluzzo, P., Capri, F. C., Vecchioni, L., Realmuto, S., Scalisi, L., Cottone, S., Nuzzo, D., & Alduina, R. (2021) · Life · doi:10.3390/life11070620 · Cited by 46 · see citing works

Feeding the gut microbiome: impact on multiple sclerosis

Bronzini, M., Maglione, A., Rosso, R., Matta, M., Masuzzo, F., Rolla, S., & Clerico, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1176016 · Cited by 46 · see citing works

Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice

Anderson, R., & Rapoport, B. L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00080 · Cited by 44 · see citing works

Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study

Chen, T., Ding, R., Chen, X., Lu, Y., Shi, J. H., Lü, Y., Tang, B., Zhang, W., Ye, C., Yuan, M., et al. (2021) · Bioengineered · doi:10.1080/21655979.2021.1982273 · Cited by 43 · see citing works

Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy

Yadav, S. K., Ito, K., & Dhib-Jalbut, S. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914756 · Cited by 43 · see citing works

The Role of Gut Immunity in Multiple Sclerosis Patients (P3.007)

Martinelli, V., Messina, M., Alberto, M., Cosorich, I., Costa, G. D., Costa, G. D., Rodegher, M., Comı, G., & Falcone, M. (2016) · Neurology · doi:10.1212/wnl.86.16_supplement.p3.007

Lymphocytes T Helper 17 in Multiple Sclerosis: Regulation by Intestinal Microbiota

Moreira, B. B. D. S., Franzoi, A. E. D. A., Gonçalves, M. V. M., Nascimento, O. J. M., & Peron, J. P. S. (2019) · Journal of Neurology and Experimental Neuroscience · doi:10.17756/jnen.2019-051 · Cited by 7 · see citing works

Characterization of fecal metabolites impact on Th17 cells differentiation in an in vitro model of Multiple Sclerosis

SANDU, A. (2024) · IRIS

A One-Two Punch in the Gut May Trigger Multiple Sclerosis

Maghzi, A., & Weiner, H. L. (2020) · Immunity · doi:10.1016/j.immuni.2020.09.016 · Cited by 11 · see citing works

Gastrointestinal influences in multiple sclerosis: Focus on the role of the microbiome

Francis, A. G., & Constantinescu, C. S. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12432 · Cited by 4 · see citing works